$AREN
Arena Group Holdings, Inc.

2013 Q4 Form 10-K Financial Statement

#000114420415019641 Filed on March 31, 2015

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.00K $300.0K $50.00K
YoY Change 20.0% 0.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $60.00K $300.0K $50.00K
YoY Change 20.0% 0.0% 0.0%
Operating Profit -$260.9K
YoY Change
Interest Expense $10.00K $100.0K -$10.00K
YoY Change -200.0% -87.5% 0.0%
% of Operating Profit
Other Income/Expense, Net $84.44K
YoY Change -89.71%
Pretax Income -$50.00K -$176.5K -$50.00K
YoY Change 0.0% -129.41% -16.67%
Income Tax $0.00 $800.00 -$10.00K
% Of Pretax Income
Net Earnings -$50.00K -$177.3K -$50.00K
YoY Change 0.0% -131.19% -16.67%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.13 -$0.02 -$0.12
COMMON SHARES
Basic Shares Outstanding 8.650M shares 8.650M shares
Diluted Shares Outstanding 8.650M shares

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.600M $2.600M $2.800M
YoY Change -7.14% -7.14% -3.45%
Cash & Equivalents $99.72K $100.0K $114.0K
Short-Term Investments $2.500M $2.500M $2.700M
Other Short-Term Assets $32.05K $0.00 $36.33K
YoY Change -11.77% 66.14%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.658M $2.700M $2.809M
YoY Change -5.35% -3.57% -4.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $2.658M $2.700M $2.809M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $2.658M $2.700M $2.809M
YoY Change -5.35% -3.57% -28.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.00K $0.00 $0.00
YoY Change -100.0%
Accrued Expenses $0.00 $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $94.24K $100.0K $125.1K
YoY Change -24.7% 0.0% 22.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $94.24K $100.0K $125.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% 0.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings -$62.09M -$61.92M
YoY Change 0.29% 2.04%
Common Stock $86.50K $83.18K
YoY Change 4.0% 3.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.396M $2.600M $2.515M
YoY Change
Total Liabilities & Shareholders Equity $2.658M $2.700M $2.809M
YoY Change -5.35% -3.57% -28.66%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income -$50.00K -$177.3K -$50.00K
YoY Change 0.0% -131.19% -16.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.00K -$143.6K -$40.00K
YoY Change -25.0% 1.19% 33.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $60.00K $130.0K -$650.0K
YoY Change -109.23% -176.47% 103.13%
Cash From Investing Activities $60.00K $129.4K -$650.0K
YoY Change -109.23% -177.45% 103.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -30.00K -$143.6K -40.00K
Cash From Investing Activities 60.00K $129.4K -650.0K
Cash From Financing Activities
Net Change In Cash 30.00K -$14.28K -690.0K
YoY Change -104.35% -95.38% 97.14%
FREE CASH FLOW
Cash From Operating Activities -$30.00K -$143.6K -$40.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
200000 shares
CY2014 dei Entity Registrant Name
EntityRegistrantName
INTEGRATED SURGICAL SYSTEMS INC
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q2 dei Entity Public Float
EntityPublicFloat
896522 USD
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000894871
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
76236 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94237 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2013Q4 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
12500 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64405084 USD
CY2013 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1238941 shares
CY2014Q3 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.16
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62094561 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13948 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
2395579 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
200000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
200000 shares
CY2014 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-12381 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84444 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19484 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 issm Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost
892901 USD
CY2014Q4 issm Available For Sale Securities Debt Maturities After Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsAmortizedCost
319192 USD
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1925012 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
542215 USD
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1932801 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
29245 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
2504261 USD
CY2014Q4 us-gaap Assets
Assets
2504261 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18000 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
70786 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
88786 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
86504 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
89496 USD
CY2014Q4 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
12500 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2658312 USD
CY2014Q4 issm Checking Account
CheckingAccount
136000 USD
CY2014Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
406000 USD
CY2014Q4 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
250000 USD
CY2014 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1321537 shares
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2540490 USD
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1925012 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
14824 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
23733 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
28772 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
15944 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2526542 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1932801 USD
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
712919 USD
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
714084 USD
CY2014Q4 issm Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
899126 USD
CY2014Q4 issm Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
319591 USD
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
108839 USD
CY2014Q4 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.18
CY2014Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2014Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2008Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
100000 shares
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
260903 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
254439 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-260903 USD
CY2013 us-gaap Investment Income Net
InvestmentIncomeNet
43334 USD
CY2014 us-gaap Investment Income Net
InvestmentIncomeNet
26415 USD
CY2013 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
32603 USD
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
5450 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-176459 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-234955 USD
CY2014Q1 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.16
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
100000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2014Q2 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.17
CY2014Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2014Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8650417 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8826876 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
200000 shares
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-254439 USD
CY2013 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
8507 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.38
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.17
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.38
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.17
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.17
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7M13D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M17D
CY2014 issm Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P4Y4M17D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M17D
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8650417 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8949645 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8650417 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8949645 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.63
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
78126 shares
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
73530 shares
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
78126 shares
CY2014Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
69446 shares
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-177259 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-235755 USD
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13250 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9849 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-2468 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-11888 USD
CY2013 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-188041 USD
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-214018 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8650417 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8826876 shares
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
56250 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
50000 USD
CY2013 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-4278 USD
CY2014 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2809 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14875 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-682 USD
CY2014Q4 issm Deferred Tax Assets Tax Credit Forward Research And Development
DeferredTaxAssetsTaxCreditForwardResearchAndDevelopment
1364000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15771000 USD
CY2014 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-143648 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-160597 USD
CY2013 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1872492 USD
CY2014 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
710797 USD
CY2013 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
271008 USD
CY2014 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
102893 USD
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1730857 USD
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1211000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
129373 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
603096 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14275 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
442499 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113991 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
800 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
800 USD
CY2013 issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
-10782 USD
CY2014 issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
21737 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
2514870 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56250 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
37500 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
15418 USD
CY2013 issm Stock To Be Issued During Period Value Common Stock
StockToBeIssuedDuringPeriodValueCommonStock
12500 USD
CY2014 issm Stock To Be Issued During Period Value Common Stock
StockToBeIssuedDuringPeriodValueCommonStock
12500 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10782 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21737 USD
CY2014 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">1. Organization and Operations</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Integrated Surgical Systems, Inc. (the &#8220;Company&#8221;) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.&#160;&#160;On June 28, 2007, the Company completed the sale of substantially all of its operating assets.&#160;&#160;After completion of the sale, the Company no longer engaged in any business activities related to its former business described above. The Company&#8217;s current operations are limited to completing a business combination or strategic alliance, if a suitable candidate is identified.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 dei Trading Symbol
TradingSymbol
ISSM
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9032979 shares
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15529000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15807000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
15567000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15807000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15567000 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14165000 USD
CY2013Q4 issm Deferred Tax Assets Tax Credit Forward Research And Development
DeferredTaxAssetsTaxCreditForwardResearchAndDevelopment
1821000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-188041 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-214018 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
800 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
800 USD
CY2013Q4 issm Deferred Income Tax Expense Benefit Beginning Balance
DeferredIncomeTaxExpenseBenefitBeginningBalance
0 USD
CY2014Q4 issm Deferred Income Tax Expense Benefit Beginning Balance
DeferredIncomeTaxExpenseBenefitBeginningBalance
0 USD
CY2013Q4 issm Deferred Income Tax Expense Benefit Ending Balance
DeferredIncomeTaxExpenseBenefitEndingBalance
0 USD
CY2014Q4 issm Deferred Income Tax Expense Benefit Ending Balance
DeferredIncomeTaxExpenseBenefitEndingBalance
0 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2013Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
0 USD
CY2014Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
0 USD
CY2013Q4 issm Deferred Tax Assets Accrued And Other Related Costs
DeferredTaxAssetsAccruedAndOtherRelatedCosts
36000 USD
CY2014Q4 issm Deferred Tax Assets Accrued And Other Related Costs
DeferredTaxAssetsAccruedAndOtherRelatedCosts
38000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
36000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
38000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13950000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-59996 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-79885 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-10295 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-13708 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
528 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
332209 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
70563 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-237816 USD
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 USD
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
15418 USD

Files In Submission

Name View Source Status
0001144204-15-019641-index-headers.html Edgar Link pending
0001144204-15-019641-index.html Edgar Link pending
0001144204-15-019641.txt Edgar Link pending
0001144204-15-019641-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
issm-20141231.xml Edgar Link completed
issm-20141231.xsd Edgar Link pending
issm-20141231_cal.xml Edgar Link unprocessable
issm-20141231_def.xml Edgar Link unprocessable
issm-20141231_lab.xml Edgar Link unprocessable
issm-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v404970_10k.htm Edgar Link pending
v404970_ex31-1.htm Edgar Link pending
v404970_ex31-2.htm Edgar Link pending
v404970_ex32-1.htm Edgar Link pending
v404970_ex32-2.htm Edgar Link pending